This inventor holds 18 USPTO granted patents and 1 published patent application. Top assignees: Microcide Pharmaceuticals, Inc., Pfizer Corporation. Active years: 1996-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Palo Alto, CA (US) (1996)
- Los Gatos, CA (US) (1997 - 2000)
Company Filing History:
Years Active: 1996-2000
Title: Inventor Scott J Hecker: Pioneering Cephalosporin Antibiotics
Introduction
Scott J Hecker, based in Los Gatos, California, is a distinguished inventor with a remarkable portfolio of 18 patents. His innovative work primarily focuses on advancements in pharmaceutical compounds, particularly in the field of antibiotics. His inventions have the potential to make a significant impact on medical treatments and antibiotic resistance.
Latest Patents
Among his latest contributions, Hecker has developed novel compounds of cephalosporin antibiotics. These compounds contain unique structures represented by complex formulas that include variations of elements such as carbon, nitrogen, and sulfur. The inventions not only encompass novel chemical compounds but also include pharmacologically acceptable salts exhibiting antibiotic activity against a wide spectrum of organisms. Notably, these compounds show efficacy against bacteria that are resistant to traditional beta-lactam antibiotics. His research extends to novel intermediates useful for synthesizing these compounds and innovative methods for their production.
Career Highlights
Throughout his career, Scott J Hecker has worked with influential pharmaceutical companies, including Microcide Pharmaceuticals, Inc., and Pfizer Corporation. His expertise in drug development and his focus on antibiotic resistance have established him as a prominent figure in the industry, contributing to significant advancements in pharmacology.
Collaborations
Hecker has collaborated with noteworthy professionals such as In-Seop Cho and Tomasz W Glinka, enhancing the creative and research processes in his innovative endeavors. These collaborations reflect his commitment to building effective teams aimed at pioneering new therapeutic solutions.
Conclusion
In conclusion, Scott J Hecker's contributions to the field of antibiotics through his patents on cephalosporin compounds are notable. His work addresses critical challenges in antibiotic resistance, showcasing his dedication to improving health outcomes. As he continues to innovate, the impact of his inventions is likely to resonate in the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile